Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Did You Know Previous | All Articles This Week | Next
This article originally posted and appeared in  DietType 2 DiabetesPreventionIssue 583

Onion Skins Help Reduce Diabetes Risk

According to the results of a new study, onion skins have now joined the list of things that could offer potential benefits for people with type 2 diabetes. The study, at the University of Madrid found that the brown skin and external layers of onions contain useful amounts of fiber and flavonoids, and that the bulbs contain sulphurous compounds and fructans. The research showed that because the brown skin of the onion was high in dietary fiber it could be used as a functional ingredient, and that two outer fleshy layers also contain flavonoids, and have a high antioxidant capacity. Onion waste could be used as a natural source of ingredients with high functional value, because this vegetable is rich in compounds that provide benefits for human health. Plant Foods for Human Nutrition July 2011

Advertisement
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 20 July, 2011 and appeared in  DietType 2 DiabetesPreventionIssue 583

Past five issues: Issue 766 | Diabetes Clinical Mastery Series Issue 225 | Issue 765 | Diabetes Clinical Mastery Series Issue 224 | Issue 764 |

2014 Most Popular Articles:

Significant Weight Loss and Drop in A1c with New Combo of Lorcaserin and Phentermine
Posted January 16, 2015
ADA Issues New Standards of Medical Care for Diabetes
Posted January 02, 2015
New Guideline Released on Pharmacological Management of Obesity
Posted January 23, 2015
Dr. Timothy Garvey on Qsymia and Other New Therapies for Weight Loss
Posted January 12, 2015
Handbook of Diabetes, 4th Ed., Excerpt #25: Specific Circumstances that Affect Diabetes Control
Posted January 04, 2015
For Your Patients: Practical Advice to Rev Up Your Workouts and Lower Fatigue
Posted January 09, 2015
Phentermine and Topirimate ER (Qsymia) Studied for Type 2 Diabetes Patients
Posted January 15, 2015
New Insulin Glargine 300 Effective in Type 1 Diabetes
Posted January 16, 2015
New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
Posted December 26, 2014
FDA Approves Weight-management Drug Saxenda
Posted December 26, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Will you prescribe inhaled insulin (Afrezza) when it becomes available this year?
CME/CE of the Week
NEW! How Do We Optimize with Antiplatelet and Anticoagulant Therapies? 
from the Acute Coronary Education Summit - July 27-28, 2011

Category: Cardiology
Time: 240 minutes



Search Articles On Diabetes In Control